Related Experiment Video
Updated: Aug 19, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats
Nathalie Mougenot1, Odile Médiani, Philippe Lechat
1Service de Pharmacologie, CHU Pitié Salpêtrière, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France. nathalie.mougenot@chups.jussieu.fr
Abstract:
Anti-hypertensive agents may differently stimulate compensatory neuro-hormonal mechanisms and induce different effects on the cardiovascular remodeling and function. The combination of low doses of the two synergistic drugs may lead to a lesser activation of counter regulatory mechanisms and could provide optimal therapeutic benefit. We evaluated on spontaneously hypertensive rats the effect of 3-week period of anti-hypertensive treatment. Rats were divided into four groups: control, bisoprolol (100 mg kg-1), hydrochlorothiazide (10 mg kg-1), and their combination with low doses (10 and 1 mg kg-1, respectively). The effects of treatment were evaluated on neuro-hormonal stimulation, cardiac and vascular structure and function. The combination had synergistic anti-hypertensive effects and significantly reduced heart rate and blood pressure but to a lower extent compared with bisoprolol 100 mg kg-1. Combination therapy was associated with a lower renin activation compared to hydrochlorothiazide alone and improved endothelial function. Cardiovascular remodeling differed between the groups: with bisoprolol, cardiac hypertrophy was reduced; with the combination therapy, the aortic media/lumen ratio was most increased. The consequent shear stress reduction may explain the associated endothelial function improvement. Such favourable cardiovascular remodeling with diuretic-beta-blockade combination may participate to the long-term cardiovascular protection during anti-hypertensive treatment.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Antihypertensive Drugs: Types of β-Blockers
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers
Heart Failure II: Pathophysiology